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Abstract
Background: Epidemiological studies have demonstrated an increased incidence of cardiovascular events in
patients with bronchial asthma, but little is known about the relationship between asthma and vascular function.
The purpose of this study was to evaluate endothelial function and arterial stiffness in children and adolescents
with asthma.
Methods: A cross-sectional controlled study was designed. Measurements of endothelial function and arterial
stiffness in asthmatic (13.6 ± 0.6 years) and control groups (14.9 ± 0.7 years) were taken by the non-invasive
peripheral arterial tonometry (EndoPAT2000) determined by using the natural logarithm of the reactive hyperemia
index (LnRHI) and the augmentation index (AIx@75%), respectively. Patients with asthma were also administered
two questionnaires to evaluate asthma control and quality of life. Exercise functional capacity was evaluated using
the Shuttle Walking Test (SWT). Only male participants were included in the present study.
Results: LnRHI and the walked distance during the SWT were similar between groups (p = 0.23 and p = 0.50,
respectively). AIx@75% was significantly higher in the asthmatic group (-7.75 ± 1.7) compared to the control group
(-15.25 ± 1.8), p < 0.04. In the control group, the LnRHI correlated positively with baseline systolic blood pressure
(r = 0.53, p = 0.02) and mean arterial pressure (r = 0.50, p = 0.03), age (r = 0.61, p = 0.007), weight (r = 0.63, p = 0.004)
and height (r = 0.56, p = 0.015). Besides that LnRHI correlated with FVC (r = 0.69, p = 0.002), FEV1, (r = 0.53, p = 0.03)
and negatively with Tiffeneau index (FEV1/FVC%, r = −0.49 p = 0.04). The LnRHI of the asthmatic group did not
correlate with the different variables evaluated.
Conclusion: The increased AIx@75% without changes in LnRHI in asthmatic patients could mean that an early
detection of vascular impairment may precede endothelial dysfunction, and that different mechanisms may
contribute to the pathogenesis and progression of cardiovascular events in this population. A large prospective
and randomized controlled study should be done to evaluate the physiopathological mechanisms underlying the
association between arterial stiffness and asthma.
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Background
Asthma is a chronic inflammatory disease with a high
prevalence that affects different age groups, especially
children [1]. The inflammation that occurs in asthma
patients is not restricted to the lungs. There is also sys-
temic inflammation, which is characterized by an in-
crease in plasma of various pro-inflammatory cytokines,
such as interleukin-6 (IL-6), tumor necrosis factor alpha
(TNF-α) and C-reactive protein (CRP) [2, 3].
Epidemiological studies have shown that asthma pa-
tients have a higher rate of cardiovascular diseases than
patients without asthma [4–7]. Recent studies show an
important association between the chronic systemic in-
flammation in asthma, and arterial stiffness, which is
considered a prognostic factor and independent pre-
dictor of cardiovascular events [8, 9]. In young adults
and children with asthma, arterial stiffness is inversely
correlated to the percentage of forced expiratory volume
in the first second (FEV1%) [9, 10], which demonstrating
that correlation between pulmonary function and vascu-
lar stiffness is not limited to aging patients [11]. More-
over, it was observed that arterial stiffness tends to
increase with asthma severity [8].
Endothelial dysfunction is currently considered to be
the first event in a series of inflammatory or immune
diseases, such as vasculitis and atherosclerosis [12]. This
observation, coupled with the knowledge that asthma is
considered an important inflammatory disease, led us to
hypothesize that endothelial function could be changed
in this population. Several studies have been recently
performed in children and adolescents to assess endo-
thelial function in different diseases [13, 14]. However,
as far as we know, no previous study has evaluated the
relationship between asthma and vascular dysfunction
measuring simultaneously the reactive hyperemia index
(RHI) and the augmentation index (Alx), noninvasive
markers of endothelial function and arterial stiffness,
respectively.
In the current study, we used EndoPAT2000 that
quantifies the endothelium-mediated changes in vascular
tone, elicited by a 5-min occlusion of the brachial artery
[15, 16]. The increase in blood flow measured by the
fingertip-mounted probe plethysmography that occurs
when the cuff is deflated, stimulates the production and
release of endothelium derived nitric oxide and cause
vasodilation [17, 18]. The dilation, manifested as reactive
hyperemia, is captured by the EndoPAT2000 as an
increase in the digital pulse volume amplitude, and the
recordings are automatically analyzed by computer-
assisted analysis software [19]. Differently, AIx is widely
used as an index of pulse wave reflection, and has been
demonstrated to be an independent predictor of a
cardiovascular event. This index modulates the central
pressure profile [20], increasing aortic systolic pressure
and decreasing aortic diastolic pressure [21]. Lower AIx
reflects better arterial elasticity [18]. In healthy children
and adolescents, EndoPAT2000 is feasible and has excel-
lent reproducibility, providing an easy and reliable means
of assessing endothelial function in this population [22].
Material and methods
Participants in the study were children and adolescents
(n = 19) with a clinical and spirometric diagnosis of asthma,
according to Global Strategy for asthma management and
prevention [1]. The control group (n = 18) was composed
of healthy children and adolescents with anthropometric
characteristics similar to the experimental group. Only male
participants were included in the present study. All experi-
mental protocols were approved by local ethics committee
(protocol number # 34878614.3.0000.5134, Comitê de
Ética e Pesquisa da Faculdade Ciências Médicas – Minas
Gerais – CEPCM-MG). All participants and parents or
legal guardians signed the Informed Consent Form (ICF).
Endothelial dysfunction and arterial stiffness were
assessed through peripheral arterial tonometry (PAT;
EndoPAT2000, Itamar Medical, Caesarea, Israel), a nonin-
vasive technology that captures a beat-to-beat plethysmo-
graphic recording of the fingers [15]. A pair of pneumatic
sensors (plethysmographic probes) was placed on the index
fingers of each hand. Baseline measurements were col-
lected for 5 min. After this time the blood pressure cuff, lo-
cated on the subject’s non-dominate arm, was inflated to
60 mmHg above baseline systolic or at least 200 mmHg of
pressure for 5 min (occlusion period), confirmed by a re-
duction of the PAT tracing to zero. After the occlusion
period, the cuff was quickly deflated to assess changes in
digital pulse volumes, a consequence of reactive hyperemia,
i.e., endothelium-dependent flow-mediated vasodilation.
To calculate the RHI, the ratio of the results of the recov-
ery (cuff deflated) and baseline periods for the test arm (A/
B) was divided by the ratio of the results of the recovery
and baseline periods for the control arm (C/D), and then
multiplied by the baseline correction factor [RHI = (A/B)/
(C/D) x baseline correction factor] (Additional file 1: Fig-
ure S3). According to the manufacturer’s recommendation,
values below 1.67 or 0.51 for the RHI or its natural loga-
rithm of the reactive hyperemia index (LnRHI), respect-
ively, characterize endothelial dysfunction [23]. These
values are still not available in the literature for the
pediatric population. The Alx was automatically calculated
by the EndoPAT2000, using the pulse waveform at rest as
a reference. The Alx was defined as the pressure difference
between the peak of the reflection wave (P2) and the peak
of the systolic wave (P1), expressed as a percentage of P1
[AIx = (P2-P1)/P1×100]. For the final analysis, the Alx was
normalized to a heart rate of 75 beats per minute
(Alx@75%). LnRHI and Alx@75% were calculated using an
automatic algorithm of the EndoPAT2000 (Software 3.1.2).
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The assessment of asthma control and quality of life
were performed using the Asthma Control Questionary-
ACQ [24] and Pediatric Asthma Quality of Life Question-
naire-PAQLQ [25], respectively, both translated and
culturally adapted to the Brazilian population [26, 27].
The assessment of functional capacity was performed
using the Shuttle Walking Test (SWT) [28]. The test
was stopped if a patient had unable to maintain the re-
quired speed or experienced dizziness, shortness of
breath, or fatigue.
Variables were described as mean ± SD. The unpaired
t-test was used to compare the pulmonary function test
parameters, LnRHI, Alx@75% and SWT, between the
groups. The Mann-Whitney test was used to compare
the differences for non-parametric data between
groups. The relationships between vascular dys-
function (LnRHI and Alx@75) and other variables
(anthropometric data, pulmonary function test and
cardiorespiratory variables) were done using Pearson
correlation coefficient or Spearman when applied.
Data analysis was performed with the software Graph-
Pad Prism version 6.0. The significance level was set
at p < 0.05.
Results
Asthma control levels considered in this study were con-
trolled (n = 7), partly controlled (n = 7) and uncontrolled
(n = 5). Asthmatic and control groups were similar in
terms of age, weight, height, BMI, and walked distance,
evaluated by SWT. The Tiffeneau index and FEV1 (%)
were significantly lower in the asthmatic group com-
pared to the control group (Table 1). Six volunteers
(31.57%) from the asthmatic group had a positive bron-
chodilator test with at least a 12% increase in the FEV1
in accordance to GINA, 2015 [29].
Based on the domains of symptoms (5.61 ± 0.26), emo-
tions (5.83 ± 0.27), activities (5.32 ± 0.30) and the general
score (5.59 ± 0.25) assessed by PAQLQ, there was a
moderate loss of quality of life in the asthmatic patients.
Figure 1 shows vascular function results. The LnRHI
did not differ between the control and asthmatic groups
(p = 0.23). However, the Alx@75% was significantly
higher in the asthmatic group (p < 0.001). In the control
group, the LnRHI correlated positively with baseline sys-
tolic blood pressure (r = 0.53, p = 0.02) and mean arterial
pressure (r = 0.50, p = 0.03), age (r = 0.61, p = 0.007),
weight (r = 0.63, p = 0.004) and height (r = 0.56, p = 0.015).
Besides that LnRHI correlated with forced vital capacity
(FVC, r = 0.69, p = 0.002), forced expiratory volume in the
first second (FEV1, r = 0.53, p = 0.03) and negatively
with Tiffeneau index (FEV1/FVC%, r = −0.49 p = 0.04).
The LnRHI of the asthmatic group did not correlate
with the different variables evaluated. (Additional file 1:
Table S1).
Discussion
As far as we know, no study has yet assessed the
markers of endothelial function and arterial stiffness in
asthmatic children and adolescents, using the Endo-
PAT2000. In this study we demonstrated that LnRHI did
not differ between the control and asthmatic groups and
the Alx@75% was significantly higher in the asthmatic
group, suggesting that the early detection of arterial stiff-
ness marker may precede endothelial dysfunction.
Long-term exposure to inflammation, even at low
levels, triggers a series of events that promote alterations
in the regulation of lipid metabolism, atherosclerosis and
endothelial dysfunction, which are precursors of cardio-
vascular disease [30, 31]. According to Tattersall et al.
[32], asthmatic patients present higher rates of car-
diovascular disease compared to participants without
asthma, suggesting that there is a shared pathophysio-
logical element between asthma and cardiovascular
disease, triggering and perpetuating different types of
comorbidities. In the present study, we investigated the
association between the endothelial and pulmonary
functions in children and adolescents with asthma. Only
male participants were included in the present study.
There is a higher probability of male children to develop
early vascular changes compared to female children of
the same age [33] and there are differences in the react-
ive hyperemia indexes when comparing male and female
Table 1 Anthropometric data, pulmonary function test and
walked distance evaluated by shuttle walking test
Variables Control Asthmatic P value
Anthropometric data
Age (years) 14.89 ± 0.68 13.58 ± 0.60 p = 0.15
Weight (Kg) 54.11 ± 3.06 51.79 ± 3.02 p = 0.59
Height (m) 1.64 ± 0.03 1.63 ± 0.03 p = 0.91
BMI (Kg/m2) 19.86 ± 0.73 19.13 ± 0.54 p = 0.42
Pulmonary function test
FVC (L) 3.85 ± 0.24 3.55 ± .29 p = 0.46
FVC (% predicted) 107.6 ± 6.62 93.2 ± 5.23 p = 0.09
FEV1(L) 3.37 ± 0.22 2.78 ± 0.27 p = 0.10
FEV1(% predicted) 99.89 ± 5.28 82.69 ± 6.24 p = 0.04
FEV1/FVC % 87.89 ± 1.72 77.04 ± 3.08 p = 0.005
Hemodynamic data
SAP(mmHg) 105.0 ± 2.02 100.9 ± 2.64 p = 0.23
DAP(mmHg) 65.83 ± 1.62 62.11 ± 1.96 p = 0.15
MAP(mmHg) 78.89 ± 1.45 75.75 ± 2.05 p = 0.22
HR(bpm) 74±3 80±2 p = 0.17
Shuttle walking test
Walked distance(m) 470.6 ± 33.03 442.4 ± 25.37 p = 0.5
FVC forced vital capacity, FEV1 forced expiratory volume in the first second,
FEV1/FVC Tiffeneau Index, SAP systolic arterial pressure, DAP diastolic arterial
pressure, MAP mean arterial pressure, HR heart rate, SWT shuttle walking test
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volunteers [33]. Moreover, females present hormonal
fluctuations during the menstruation period and the first
years of puberty, which can interfere with measure-
ments. It is also difficult to control the use of contracep-
tives in adolescents, another important factor that
contributed to the endothelium dysfunction. Also, only
participants with a normal BMI were included in the
present study because overweight and obesity are factors
that lead to endothelial dysfunction [34].
In the current study, the LnRHI of the asthmatic
group did not differ from control group. Similar results
were observed by Moore et al. [35] through flow medi-
ated dilation (FMD) technique, based on the same
physiological mechanism of PAT [15]. A main advantage
of the EndoPAT2000 system on FMD is that the contra-
lateral arm serves as an internal control of measurement
[36] and this technique is operator-independent [36]. In
addition, EndoPAT2000 enables the simultaneous meas-
urement of endothelial function and arterial stiffness. In
the current study, LnRHI of control group correlated
positively with baseline systolic blood pressure and mean
arterial pressure, anthropometric data (age, weight,
height), and pulmonar function test parameters (FVC,
FEV1). In addition, in control group the LnRHI corre-
lated negatively with Tiffeneau index. A large sample
sized, prospective and randomized controlled study
should be addressed to evaluate the value of these
associations.
According to Harkness et al. [37] asthma is not only
an airway disease, but a vascular disease due to an
expansion and morphological dysregulation of the bron-
chial vascular network in the airways of asthmatics, such
as an increased number, size and density of blood
vessels, as well as vascular leakage and plasma engorge-
ment. Recently we demonstrated [38, 39] in a model of
chronic asthma induced by ovalbumin (OVA) that asth-
matic mice exhibited an increase in size and number of
vessels within the airway wall, contributing to thickening
of the wall. OVA mice also presented a significant
increase in myocyte diameter of the right ventricle,
suggesting that structural remodeling led to an increase
in pulmonary vascular resistance and subsequent right
ventricular hypertrophy. However, the pathophysiological
impact of the increased vasculature in the bronchial wall
and its significance to pulmonary function in asthma [37]
and systemic circulation is unrecognized at this time.
Accumulating data have shown an important associ-
ation between chronic systemic inflammation in asthma
and arterial stiffness [9–11], which is considered a prog-
nostic factor and an independent predictor of cardiovas-
cular events [8]. In the present study, the Alx@75% was
significantly higher in the asthmatic group but different
from other authors [8–10], there was no correlation be-
tween this index and the pulmonary function parameters
and reversibility of airway obstruction in the asthmatic
group. This suggests that, besides airway obstruction,
there are other factors contributing to the higher inci-
dence of cardiovascular outcomes in this population.
The results of Moore et al. [35] corroborates with this
line of thought. Moore et al. [35] compared the arterial
stiffness in asthmatic adults (18 to 45 years), having con-
trolled and partially controlled asthma, with healthy vol-
unteers, which were matched for age, body mass index,
level of physical activity, and maximum oxygen con-
sumption (VO2max). These authors observed that arter-
ial stiffness was significantly higher in patients with
Fig. 1 Vascular function, given by the, natural logarithm of the reactive hyperemia index (LnRHI) and the augmentation index corrected for a
heart rate of 75 bpm (AIx@75%). **p < 0.001 compared to the control group
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asthma, suggesting that structural changes in arterial
vessels are related to pulmonary disease and are not a
consequence of reduced physical activity or VO2max.
Similarly to Moore et al. [35] results, in the present
study healthy volunteers were matched for age, high,
body mass index, and exercise functional capacity.
Despite the exclusion of factors that could mislead the
identification of endothelial dysfunction, such as female
gender, changes in the BMI, smoking and diseases that can
compromise endothelial function such as diabetes, this
study has some limitations. The first limitation is the lack
of knowledge about the lipid profile of the participants. In-
flammatory and hemostatic abnormalities present in chil-
dren with familiar hypercholesterolemia contribute to
endothelial dysfunction [40]. Another limitation of this
study was the lack of assessment of the pubertal stage of
the participants. Endothelial function increases during pu-
berty. Children at advanced stages of pubertal development,
assessed by the scale of Tanner, have a greater peripheral
vasodilator response measured by PAT [41]. Lastly, black
volunteers were not excluded from the study. This ethnicity
is usually associated with impaired vascular function com-
pared to whites, due to the lower bioactivity of nitric oxide
in the microcirculation of the forearm, which is associated
with a reduced vasodilator response of the smooth muscle
in response to nitric oxide donors [42].
In conclusion, this study demonstrated that LnRHI did
not differ between the groups and the Alx@75% was signifi-
cantly higher in the asthmatic group. The increase in
Alx@75% in asthmatic patients, with no changes in LnRHI,
may indicate that early detection of vascular dysfunction
may precede endothelial dysfunction and that different
mechanisms may contribute to the pathogenesis and pro-
gression of cardiovascular events in this population.
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